Literature DB >> 25458588

Cancer-related and treatment-related fatigue.

Xin Shelley Wang1, Jeanie F Woodruff2.   

Abstract

Fatigue is a distressing and persistent symptom for patients with gynecological cancer and for survivors. Debilitating cancer-related fatigue (CRF) is produced by both the disease and its treatment. Although awareness and study of CRF have grown in recent years, consistent assessment has not been a priority in routine medical practice. The pathophysiological mechanisms that induce CRF remain unclear, and effective pharmacological interventions have yet to be established. Based on the literature and our own research results, this review focuses on recent progress toward understanding the nature and causes of CRF and on several promising treatment modalities. Given the prevalence and severity of CRF in the gynecological cancer patient population, establishing standardized fatigue measurement and management methods in routine clinical oncology care is of utmost importance. Whether CRF has an underlying inflammatory cause is still hypothetical, however, and no mechanism-driven symptom intervention is currently in clinical use, even though the development of such interventions would provide patients with greater symptom control. Advancing translational and clinical fatigue research will require anatomical pathway studies and well-designed clinical investigations that focus on the development of mechanism-driven interventions based on physiological-behavioral fatigue research, implementation of guidelines for experimental designs, and discovery of biomarkers identifying individuals at high risk for CRF. Validated patient-reported outcomes measures are an essential component of such clinical studies. Because numerous subscales, unidimensional measures, and multidimensional measures exist, clinicians and researchers should consider individual circumstances, good clinical practice, and research goals as guides for choosing the most appropriate fatigue measurement tool. Additionally, education about CRF should be made available to all patients and their caregivers, as accurate and age-appropriate information about conditions like CRF can alleviate much of the stress and anxiety brought on by poor communication about this distressing condition.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Brief Fatigue Inventory; Cancer-related fatigue; Gynecological cancer; Patient-reported outcomes

Mesh:

Substances:

Year:  2014        PMID: 25458588      PMCID: PMC4355326          DOI: 10.1016/j.ygyno.2014.10.013

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  66 in total

Review 1.  The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review.

Authors:  Christian Schubert; Suzi Hong; Loki Natarajan; Paul J Mills; Joel E Dimsdale
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

2.  The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory.

Authors:  T R Mendoza; X S Wang; C S Cleeland; M Morrissey; B A Johnson; J K Wendt; S L Huber
Journal:  Cancer       Date:  1999-03-01       Impact factor: 6.860

3.  When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.

Authors:  Ronald C Serlin; Tito R Mendoza; Yoshio Nakamura; Katherine R Edwards; Charles S Cleeland
Journal:  Pain       Date:  1995-05       Impact factor: 6.961

4.  Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2.

Authors:  Debra L Barton; Heshan Liu; Shaker R Dakhil; Breanna Linquist; Jeff A Sloan; Craig R Nichols; Travis W McGinn; Philip J Stella; Grant R Seeger; Amit Sood; Charles L Loprinzi
Journal:  J Natl Cancer Inst       Date:  2013-07-13       Impact factor: 13.506

5.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

Authors:  L B Krupp; N G LaRocca; J Muir-Nash; A D Steinberg
Journal:  Arch Neurol       Date:  1989-10

6.  Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy.

Authors:  Joseph A Roscoe; Gary R Morrow; Jane T Hickok; Karen M Mustian; Jennifer J Griggs; Sara E Matteson; Peter Bushunow; Raman Qazi; Brian Smith
Journal:  Breast Cancer Res Treat       Date:  2005-02       Impact factor: 4.872

7.  Pain and its treatment in outpatients with metastatic cancer.

Authors:  C S Cleeland; R Gonin; A K Hatfield; J H Edmonson; R H Blum; J A Stewart; K J Pandya
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

8.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

Review 9.  Depressive disorders and immunity: 20 years of progress and discovery.

Authors:  Michael R Irwin; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2007-03-13       Impact factor: 7.217

10.  The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue.

Authors:  E M Smets; B Garssen; B Bonke; J C De Haes
Journal:  J Psychosom Res       Date:  1995-04       Impact factor: 3.006

View more
  39 in total

1.  Cancer-related fatigue and its determinants in a cohort of women with breast cancer: the DAMA Cohort.

Authors:  R Puigpinós-Riera; G Serral; M Sala; X Bargalló; M J Quintana; M Espinosa; R Manzanera; M Doménech; F Macià; J Grau; E Vidal
Journal:  Support Care Cancer       Date:  2020-02-20       Impact factor: 3.603

Review 2.  The biology of cancer-related fatigue: a review of the literature.

Authors:  Leorey N Saligan; Karin Olson; Kristin Filler; David Larkin; Fiona Cramp; Sriram Yennurajalingam; Yennu Sriram; Carmen P Escalante; Auro del Giglio; Kord M Kober; Jayesh Kamath; Oxana Palesh; Karen Mustian
Journal:  Support Care Cancer       Date:  2015-05-15       Impact factor: 3.603

3.  Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype.

Authors:  Hannah E Wilson; David A Stanton; Cortney Montgomery; Aniello M Infante; Matthew Taylor; Hannah Hazard-Jenkins; Elena N Pugacheva; Emidio E Pistilli
Journal:  NPJ Breast Cancer       Date:  2020-06-04

Review 4.  Making Cancer Rehabilitation Services Work for Cancer Patients: Recommendations for Research and Practice to Improve Employment Outcomes.

Authors:  Catherine M Alfano; Erin E Kent; Lynne S Padgett; Melvin Grimes; Janet S de Moor
Journal:  PM R       Date:  2017-09       Impact factor: 2.298

5.  Transcutaneous electrical acupoint stimulation (TEAS) relieved cancer-related fatigue in non-small cell lung cancer (NSCLC) patients after chemotherapy.

Authors:  Lili Hou; Caicun Zhou; Yifan Wu; Ying Yu; Yinqing Hu
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

6.  Understanding cancer-related fatigue: advancing the science.

Authors:  Michael Renner; Leorey N Saligan
Journal:  Fatigue       Date:  2016-10-26

7.  Nausea and disturbed sleep as predictors of cancer-related fatigue in breast cancer patients: a multicenter NCORP study.

Authors:  Anita R Peoples; Joseph A Roscoe; Robert C Block; Charles E Heckler; Julie L Ryan; Karen M Mustian; Michelle C Janelsins; Luke J Peppone; Dennis F Moore; Charlotte Coles; Karen L Hoelzer; Gary R Morrow; Ann M Dozier
Journal:  Support Care Cancer       Date:  2016-12-20       Impact factor: 3.603

8.  Nordic Walking and the Isa Method for Breast Cancer Survivors: Effects on Upper Limb Circumferences and Total Body Extracellular Water - a Pilot Study.

Authors:  Andrea Di Blasio; Teresa Morano; Giorgio Napolitano; Ines Bucci; Serena Di Santo; Sabina Gallina; Lucia Cugusi; Francesco Di Donato; Alberto D'Arielli; Ettore Cianchetti
Journal:  Breast Care (Basel)       Date:  2016-12-05       Impact factor: 2.860

9.  Identifying and Implementing Endpoints for Geriatric Mice.

Authors:  Linda A Toth
Journal:  Comp Med       Date:  2018-11-28       Impact factor: 0.982

10.  A Pilot Study Using a Multistaged Integrated Analysis of Gene Expression and Methylation to Evaluate Mechanisms for Evening Fatigue in Women Who Received Chemotherapy for Breast Cancer.

Authors:  Elena Flowers; Annesa Flentje; Jon Levine; Adam Olshen; Marilyn Hammer; Steven Paul; Yvette Conley; Christine Miaskowski; Kord M Kober
Journal:  Biol Res Nurs       Date:  2019-01-31       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.